Table 2.
Cell line | Diagnosis | Methylation | Expression | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
PTEN | MGMT | RASSF1A | p14 | p16 | PTEN | MGMT | RASSF1A | p14 | p16 | ||
T98G | GBM | − | ■ | ■ | − | * | + | + | − | − | − |
LN-405 | GBM | − | ■ | □ | − | − | + | − | −/+ | + | + |
U118 | GBM | − | ■ | ■ | * | * | § | § | § | § | § |
U251 | GBM | − | ■ | ■ | * | * | § | § | § | § | § |
U87 | GBM | − | ■ | ■ | * | * | + | − | − | − | − |
MOG-G-CCM | AIII | □ | ■ | ■ | − | * | + | + | − | + | + |
SW1088 | AIII | − | ■ | □ | * | * | − | − | −/+ | − | − |
SW1783 | AIII | − | − | ■ | − | − | + | + | − | + | + |
GOS3 | A/O (II/III) | □ | − | ■ | * | − | + | − | − | − | − |
GBM: glioblastoma multiforme; AIII: anaplastic astrocytoma; A/O: astrocytoma/oligodendroglioma. ■: methylated; □: hemimethylated; +: expression; −/+: low expression; −: lack of expression/absence of methylation; *: nonanalyzed; §: nonstudied.